The Clinical Performance of the BioCode Respiratory Pathogen Panel for the Detection of Viruses and Bacteria from Nasopharyngeal Swabs-Reference-Cited by-同舟云学术

The Clinical Performance of the BioCode Respiratory Pathogen Panel for the Detection of Viruses and Bacteria from Nasopharyngeal Swabs

Published:2023-06-15 Issue:3 Volume:11 Page:
ISSN:2165-0497
Container-title:Microbiology Spectrum
language:en
Short-container-title:Microbiol Spectr

Author:

Zhang Xin¹²,Knoth Colleen³,Pham Anh³,Lima Amorce⁴,Dominguez Rosario⁵,Ibarra-Flores Irvin⁵,Lopez Juan C.¹,Uy Dominic⁴,Silbert Suzane⁴,Patel Anami⁶,Aye Michael³,Tang Yi-Wei¹,Dien Bard Jennifer⁵⁷^ORCID

Affiliation:

1. Memorial Sloan Kettering Cancer Center, New York, New York, USA

2. Sichuan Academy of Medicine & Sichuan Provincial People’s Hospital, Chengdu, China

3. Applied BioCode Inc., Santa Fe Springs, California, USA

4. Tampa General Hospital, Tampa, Florida, USA

5. Department of Pathology and Laboratory Medicine, Children’s Hospital Los Angeles, Los Angeles, California, USA

6. PathAI Diagnostics, Memphis, Tennessee, USA

7. Keck School of Medicine, University of Southern California, Los Angeles, California, USA

Abstract

Early detection of microbial pathogens causing respiratory tract infection plays a crucial role in clinical management. The BioCode Respiratory Pathogen Panel (BioCode RPP) is a high-throughput test that utilizes RT-PCR in combination with barcoded magnetic beads to amplify, detect, and identify 17 respiratory pathogens, including 14 viruses and 3 bacteria.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Cell Biology,Microbiology (medical),Genetics,General Immunology and Microbiology,Ecology,Physiology

Link

https://journals.asm.org/doi/pdf/10.1128/spectrum.04044-22

Reference24 articles.

1. Molecular Testing for Acute Respiratory Tract Infections: Clinical and Diagnostic Recommendations From the IDSA’s Diagnostics Committee

2. Point-Counterpoint: Large Multiplex PCR Panels Should Be First-Line Tests for Detection of Respiratory and Intestinal Pathogens

3. Centers for Disease Control and Prevention. Summary of the 2017–2018 influenza season. https://www.cdc.gov/flu/about/season/flu-season-2017-2018.htm.

4. Centers for Disease Control and Prevention. Estimated flu-related illnesses medical visits hospitalizations and deaths in the United States—2018–2019 flu season. https://www.cdc.gov/flu/about/burden/2018-2019.html.

5. Comparative Performance of the Luminex NxTAG Respiratory Pathogen Panel, GenMark eSensor Respiratory Viral Panel, and BioFire FilmArray Respiratory Panel